Local drugmakers enjoy unsolicited gains over Tylenol trouble

Published: 2013-05-24 06:58:00

Updated: 2013-05-24 06:58:00

Janssen Korea’s competitors are enjoying unexpected benefits these says as the Ministry of Food and Drug Safety (MFDS) on May 16 ordered Janssen Korea to suspend production of five types of medicine for up to five months.

The five medicines subject to the ban in question are fever reliever Chi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK